...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Endocyte Valuation
4
Oct 18, 2018 02:14PM
2
Oct 18, 2018 02:35PM

This tiny biotech spun a quick $2 billion from $12 million

Marketwatch story on Lu-PSMA-617 Endocyte/Novartis. Thanks to Chrispi on BiOasis Stockhouse page for sharing.

BDAZ

2
Oct 19, 2018 01:00PM
4
Oct 25, 2018 11:38AM
3
Oct 31, 2018 02:39PM
6
Oct 31, 2018 03:26PM
6
Nov 01, 2018 04:40PM
5
Nov 02, 2018 03:03AM
5
Nov 02, 2018 06:00PM
6
Nov 03, 2018 01:31PM
Share
New Message
Please login to post a reply